For standard proliferation assays 2 × 10
5 PBMCs were cultured in R10 medium (composed of
RPMI 1640 media (Biochrom, Berlin, Germany) supplemented with 10% FCS, 1 mM
l-glutamine, 50 U/mL penicillin, 0.5 mM sodium pyruvate, and 50 μg/mL streptomycin) for 48 h with PHA, ConA, PWM, and immobilized CD3 mAb (iCD3) either with or without soluble co-stimulatory anti-CD28 (1 μg/mL), respectively. For immobilization 100 µL anti-CD3 (OKT3, 2.5 μg/mL; purified from hybridoma supernatant) was adsorbed onto Nunc Maxi-Sorb 96-well plates (Sigma Aldrich, St. Louis, MO, USA) for 60 min at 37 °C. The plate was washed three times. Proliferation of CD4
+ T cells was assessed after magnetic enrichment of the target cells from frozen PBMC after thawing using the IMag CD4 T Lymphocyte Enrichment Set (Becton Dickinson, Heidelberg, Germany) and incubating 5 × 10
4 cells/well with media, PHA and iCD3 either with or without soluble co-stimulatory anti-CD28 (1μg/mL), respectively, in triplicates for 72 h. Radioactive thymidine was added to each well. 24 h later cells were harvested and incorporated radioactivity was determined using a beta-counter.
Sogkas G., Dubrowinskaja N., Bergmann A.K., Lentes J., Ripperger T., Fedchenko M., Ernst D., Jablonka A., Geffers R., Baumann U., Schmidt R.E, & Atschekzei F. (2019). Progressive Immunodeficiency with Gradual Depletion of B and CD4+ T Cells in Immunodeficiency, Centromeric Instability and Facial Anomalies Syndrome 2 (ICF2). Diseases, 7(2), 34.